Back

Analysis of patient characteristics as covariates potentially affecting pharmacokinetics, efficacy, or safety of betrixaban in the APEX study

29 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Best Posters 6 - Best Posters in prevention, interventions and outcomes Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Janet Leeds

South San Francisco (United States of America)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Y. Park (Seoul, KR)
Abstract
Presentation thumbnail
Mr R. Gascuena (Leganes, ES)
Abstract Slides
Presentation thumbnail
Professor J. Ferrieres (Toulouse, FR)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 6 - Best Posters in prevention, interventions and outcomes

The Event

Event poster

ESC Congress 2017

29 August 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources